AnaptysBio, Inc.
September 30, 2025 - by Joey Ramson
$ANAB, a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, is up today as it announced that it has approved plans to explore separating its business into two independent, publicly traded companies.
